Literature DB >> 21997336

Drugs of abuse effects on immunity and microbial pathogenesis.

Sabita Roy1.   

Abstract

Substance abuse remains a serious medical, public health, and social problem. The impact on destructive public health and health costs compounded with the negative consequences of drugs abuse poses a significant toll on the economy. Despite significant advancement of research in the field treatment of and care of patients with substance abuse has lagged behind because of limited education and training of clinicians on substance abuse problems. The goal of the special issue is to provide the current status on the mechanisms underlying the increased prevalence of opportunistic infections in the drug abuse population, to identify important areas where further research would be beneficial and to open new avenues of investigation for therapeutic development. We aimed these articles for the benefit of both basic and clinical researchers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21997336     DOI: 10.1007/s11481-011-9318-z

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  26 in total

Review 1.  Cannabinoid neuroimmune modulation of SIV disease.

Authors:  Patricia E Molina; Angela Amedee; Nicole J LeCapitaine; Jovanny Zabaleta; Mahesh Mohan; Peter Winsauer; Curtis Vande Stouwe
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-10       Impact factor: 4.147

Review 2.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

Review 3.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

Review 4.  Methods for comparing drug policies--the utility of composite drug harm indexes.

Authors:  Alison Ritter
Journal:  Int J Drug Policy       Date:  2009-04-08

5.  Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat.

Authors:  Daniel Fraga; Erinn S Raborn; Gabriela A Ferreira; Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-07       Impact factor: 4.147

6.  The role of IL-1β in nicotine-induced immunosuppression and neuroimmune communication.

Authors:  Seddigheh Razani-Boroujerdi; Raymond J Langley; Shashi P Singh; Juan Carlos Pena-Philippides; Jules Rir-sima-ah; Sravanthi Gundavarapu; Neerad C Mishra; Mohan L Sopori
Journal:  J Neuroimmune Pharmacol       Date:  2011-06-14       Impact factor: 4.147

7.  Nociceptin/orphanin FQ receptor-driven heterologous desensitization of the major HIV-1 co-receptor CXCR4.

Authors:  David E Kaminsky; Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2011-06-09       Impact factor: 4.147

Review 8.  Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission.

Authors:  Judith A Cook
Journal:  Life Sci       Date:  2011-01-08       Impact factor: 5.037

Review 9.  Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.

Authors:  Sabita Roy; Jana Ninkovic; Santanu Banerjee; Richard Gene Charboneau; Subhas Das; Raini Dutta; Varvara A Kirchner; Lisa Koodie; Jing Ma; Jingjing Meng; Roderick A Barke
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

Review 10.  Interventions for HIV and hepatitis C virus infections in recreational drug users.

Authors:  Jag H Khalsa; Ahmed Elkashef
Journal:  Clin Infect Dis       Date:  2010-06-01       Impact factor: 9.079

View more
  1 in total

1.  The first Insubria autumn school on neuroimmunopharmacology: challenging paradigms beyond boundaries.

Authors:  Marco Cosentino; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2013-02-12       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.